Myoblast Transfer Therapy in the New Millennium by Miranda D. Grounds

Get full text

A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle by Basma A. Al-Mshhdani, Miranda D. Grounds, Peter G. Arthur, Jessica R. Terrill

Get full text

Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice. by Erin M Lloyd, Hongyang Xu, Robyn M Murphy, Miranda D Grounds, Gavin J Pinniger

Get full text

Correction: Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice. by Erin M Lloyd, Hongyang Xu, Robyn M Murphy, Miranda D Grounds, Gavin J Pinniger

Get full text

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic <i>mdx</i> Mice by Jessica R. Terrill, Angelo Patrick R. Bautista, Irene Tsioutsias, Miranda D. Grounds, Peter G. Arthur

Get full text

Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy. by Hannah G Radley-Crabb, Juan C Marini, Horacio A Sosa, Liliana I Castillo, Miranda D Grounds, Marta L Fiorotto

Get full text

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the <i>mdx</i> Mouse Model for Duchenne Muscular Dystrophy by Jessica R. Terrill, Corinne Huchet, Caroline Le Guiner, Aude Lafoux, Dorian Caudal, Ankita Tulangekar, Robert J. Bryson-Richardson, Tamar E. Sztal, Miranda D. Grounds, Peter G. Arthur

Get full text

Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy by Erin M. Lloyd, Rachael C. Crew, Vanessa R. Haynes, Robert B. White, Peter J. Mark, Connie Jackaman, John M. Papadimitriou, Gavin J. Pinniger, Robyn M. Murphy, Matthew J. Watt, Miranda D. Grounds

Get full text